Qublan H, Amarin Z, Nawasreh M, Diab F, Malkawi S, Al-Ahmad N, Balawneh M
Department of Obstetrics and Gynaecology, Prince Rashid Hospital, Royal Medical Services, Irbid, Jordan.
Hum Reprod. 2006 Aug;21(8):2110-3. doi: 10.1093/humrep/del113. Epub 2006 Apr 13.
The objective of this study was to determine the incidence and recurrence rate of luteinized unruptured follicle (LUF) syndrome in women with unexplained infertility undergoing intrauterine insemination (IUI).
A total of 167 women with unexplained infertility who underwent 292 cycles of IUI were enrolled in the study. All patients were treated with clomiphene citrate, 50-150 mg/daily from day 5 to 9 of their menstrual cycle. Ultrasound examination to confirm ovulation was performed on the day of IUI (day 0) and every day thereafter for another 3 days (days 1, 2 and 3). A total of 69 women who failed to conceive in the first cycle and 56 women who failed to conceive in the second cycle underwent second and third cycles, respectively.
Of the total 167 patients who underwent first cycle, 42 (25%) had LUF. The incidence of LUF was 56.5% in 69 patients who underwent a second cycle of IUI treatment, of whom 33 patients had LUF in the first cycle with recurrence rate of 78.6%. In 56 patients who underwent 3 consecutive cycles, the incidence of LUF was 58.9% and recurrence rate of 90%. No pregnancies were recorded in patients with LUF during the study period.
The incidence and recurrence rate of LUF are significantly increased in subsequent cycles of IUI. In these patients, other options of infertility treatment might be justified.
本研究的目的是确定接受宫内人工授精(IUI)的不明原因不孕症女性中黄素化未破裂卵泡(LUF)综合征的发生率和复发率。
共有167例不明原因不孕症女性接受了292个周期的IUI治疗并纳入研究。所有患者均接受枸橼酸氯米芬治疗,在月经周期的第5至9天每天服用50 - 150毫克。在IUI当天(第0天)及之后的3天(第1、2和3天)进行超声检查以确认排卵。共有69例在第一个周期未受孕的女性和56例在第二个周期未受孕的女性分别接受了第二个和第三个周期的治疗。
在接受第一个周期治疗的167例患者中,42例(25%)发生LUF。在接受第二个周期IUI治疗的69例患者中,LUF的发生率为56.5%,其中33例在第一个周期发生LUF,复发率为78.6%。在56例接受连续3个周期治疗的患者中,LUF的发生率为58.9%,复发率为90%。在研究期间,LUF患者未记录到妊娠。
在IUI的后续周期中,LUF的发生率和复发率显著增加。对于这些患者,其他不孕症治疗选择可能是合理的。